APO 027
Pill imprint APO 027 has been identified as Ticlopidine hydrochloride 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlopidine hydrochloride Images
- Imprint:
-
APO 027
- Strength:
- 250 mg
- Color:
- White
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
microcrystalline cellulose
stearic acid
hydroxypropyl methylcellulose
polyethylene glycol
titanium dioxide
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0027
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-5378 | Major Pharmaceuticals |
Note: Inactive ingredients may vary.
Advertisement
More Ticlopidine Hydrochloride resources
- Ticlopidine (Wolters Kluwer)
- ticlopidine (Cerner Multum)
- ticlopidine (Micromedex) - Includes Dosage Information
- Ticlopidine Hydrochloride (AHFS DI)
- Ticlopidine (FDA)
- Ticlopidine Hydrochloride (Wolters Kluwer)
Search Again
